keep
potenti
synergi
biolog
activ
synthet
anomal
deriv
deazapurin
lascorb
acid
laa
mind
synthes
new
deriv
lascorb
iminolascorb
acid
novel
compound
evalu
cytostat
antivir
activ
vitro
panel
human
malign
tumour
cell
line
normal
murin
fibroblast
among
evalu
compound
deriv
laa
exert
potent
inhibitori
activ
growth
cell
ic
mm
strong
antiprolif
effect
ic
mm
deriv
laa
show
best
effect
hela
cell
ic
mm
promin
effect
ic
mm
furthermor
deriv
disubstitut
two
iminolaa
moieti
show
best
activ
tumour
cell
ic
mm
pronounc
antiprolif
effect
cell
ic
mm
compound
show
select
cytostat
effect
tumour
cell
line
comparison
embryon
murin
fibroblast
evalu
antivir
activ
deriv
laa
exhibit
highest
activ
laboratoryadapt
strain
human
cytomegaloviru
hcmv
davi
ec
valu
compar
wellknown
antihcmv
drug
ganciclovir
without
cytotox
effect
normal
human
embryon
lung
hel
cell
numer
nucleosid
deriv
use
treatment
viral
tumour
bacteri
well
diseas
purin
nucleosid
antivir
drug
carbovir
didanosin
prodrug
current
use
treatment
human
immunodefici
viru
hiv
caus
diseas
aid
acyclovir
ganciclovir
penciclovir
adenin
dhpa
use
nucleosid
antiherpet
drug
moreov
thioguanin
use
antitumour
drug
azathioprin
immunosuppress
drug
use
organ
transplant
recipi
cladiribin
treatment
system
mastocytosi
aim
synthes
better
select
substanc
modif
sugar
moieti
analogu
replac
alter
nucleosid
base
investig
synthet
biolog
thu
potent
inhibitor
sadenosylhomocystein
hydrolas
attract
target
design
antivir
drug
shown
signific
activ
hiv
oncogen
dna
virus
deriv
cyclopentyl
adenin
drug
aristeromycin
neoplanocin
retain
strong
activ
vaccinia
viru
hepat
c
viru
hcv
lower
cytotox
also
shown
wide
spectrum
activ
dna
rna
virus
well
antitumour
activ
halogen
deriv
show
antihbv
activ
broad
spectrum
antitumour
properti
strong
abil
subtract
mycobacterium
tuberculosi
adenosin
kinas
fluorin
methyl
deriv
natur
isol
antibiot
tubercidin
shown
strong
inhibit
nonstructur
hepat
c
protein
halogen
also
exhibit
substanti
activ
human
cytomegaloviru
hcmv
acycl
deriv
sangivamycin
broad
spectrum
antibiot
show
antivir
activ
herp
simplex
viru
hcmv
refer
drug
ganciclovir
without
cytotox
effect
addit
compound
prodrug
preclin
candid
treatment
hepatocellular
carcinoma
furthermor
fluorin
alkyl
dideoxi
deriv
shown
broad
spectrum
antitumour
activ
lower
cytotox
relat
research
group
synthes
numer
nucleosid
deriv
lascorb
acid
demonstr
broad
spectrum
antiprolif
activ
well
antihcmv
antivzv
anticmv
activ
micromolar
concentr
alter
sugar
moieti
natur
synthet
nucleosid
lascorb
acid
succeed
antioxid
properti
antitumour
properti
stearat
palmit
deriv
find
prompt
us
synthes
new
type
various
halogen
alkyl
deriv
lascorb
iminolascorb
acid
fig
primari
aim
evalu
antivir
potenc
cytotox
activ
deriv
lascorb
acid
prepar
modifi
reaction
condit
scheme
base
b
c
silyl
either
hmd
catalyt
amount
ammoniumsulph
b
c
bi
trimethylsilyl
acetamid
bsa
condens
reaction
situ
silyl
base
b
c
acid
dadbaa
synthes
previous
describ
friedelecraft
catalyst
trimethylsilyltrifluoromethan
sulphon
tmsotf
afford
new
deriv
lascorb
acid
scheme
contain
ethylen
spacer
two
moieti
base
b
synthes
six
step
previous
describ
liu
mc
et
al
base
synthes
cycliz
reaction
diethoxymethyl
acet
dema
deriv
laa
isol
regioisom
mixtur
z
e
isom
ratio
reaction
base
b
dadbaa
result
two
regioisom
z
isom
mixtur
z
e
isom
ratio
deriv
laa
isol
regioisom
equal
z
e
isom
amount
ammonolysi
compound
dioxan
methanol
gave
compound
bear
hydroxi
group
iminolascorb
acid
iminolaa
also
substitut
fluorin
atom
amino
group
posit
base
occur
synthesi
deriv
iminolaa
compound
underw
debenzyl
borontrichlorid
dichloromethan
yield
compound
deriv
laa
free
hydroxi
group
posit
laa
mixtur
z
e
isom
ratio
deriv
laa
prepar
similar
manner
compound
condens
reaction
base
dadbaa
reaction
condit
gave
regioisom
compound
z
e
scheme
deriv
laa
isol
condit
success
obtain
via
reaction
mitsunobu
reaction
condit
reaction
base
e
acid
hdbaa
triphenylphosphin
pph
diethyl
azodicarboxyl
dead
afford
compound
substitut
acid
posit
isom
ratio
z
e
scheme
ammonolysi
compound
similar
procedur
synthesi
deriv
iminolaa
gave
deriv
iminolaa
bear
amino
group
chiral
posit
lactam
moieti
scheme
oppos
structur
analogu
deriv
deazapurin
iminolaa
describ
paper
contain
ethyl
spacer
deazapurin
lactam
moieti
compound
contain
ethylen
spacer
two
moieti
doubl
bond
atom
structur
differ
product
may
explain
mechan
lactam
aris
mechan
format
lactam
lascorb
acid
involv
nucleophil
attack
ammonia
carbonyl
group
lacton
moieti
concomit
lacton
ring
open
format
ketoenol
tautom
subsequ
close
form
lactam
thu
find
two
structur
differ
compound
may
accord
mechan
keto
tautom
undergo
nucleophil
attack
amino
group
follow
ring
closur
format
lactam
deriv
wherea
enol
tautom
undergo
nucleophil
attack
follow
consecut
shift
doubl
bond
format
iminolaa
deriv
deriv
laa
prepar
mitsunobu
reaction
condit
via
similar
synthet
method
obtain
deriv
laa
scheme
reaction
base
f
hdbaa
gave
regioisom
equal
isom
ratio
z
e
reaction
base
g
hdbaa
yield
two
condens
deriv
monosubstitut
acid
posit
disubstitut
laa
posit
z
z
relat
doubl
bond
ammonolysi
compound
produc
deriv
iminolaa
ammonolysi
gave
deriv
iminolaa
scheme
subdu
ammonia
disubstitut
deriv
laa
yield
two
deriv
iminolaa
presum
diasteroisomer
relat
scheme
chemic
ident
deazapurin
deriv
lascorb
acid
iminolascorb
acid
confirm
h
c
n
f
nmr
measur
well
mass
spectrometri
spectra
analysi
hplcmsm
malditoftof
nmr
chemic
shift
report
tabl
h
experiment
section
h
c
supplementari
data
f
n
h
decoupl
c
nmr
spectra
show
cef
coupl
constant
enabl
straightforward
identif
fluorin
carbon
atom
neighbour
notabl
display
differ
multipl
pattern
due
longrang
coupl
constant
two
fluorin
atom
coupl
fluorin
atom
three
bond
j
hz
wherea
show
coupl
constant
two
j
hz
four
bond
j
hz
furthermor
fe
c
nmr
spectra
allow
unambigu
assign
difluorin
deazapurin
fig
regioisom
distinguish
basi
heteronuclear
c
n
correl
signal
hmbc
spectra
methylen
proton
ppm
show
correl
signal
ppm
suggest
benzylprotect
ascorb
acid
attach
posit
deazapurin
scaffold
n
chemic
shift
deazapurin
observ
ppm
respect
contrast
perus
nmr
spectra
show
correl
signal
methylen
proton
ppm
ppm
indic
reaction
proceed
posit
deazapurin
moieti
n
chemic
shift
deazapurin
corrobor
ascorb
acid
attach
posit
observ
ppm
respect
distinct
shield
well
atom
regioisomer
pair
facilit
assess
structur
featur
remain
regioisom
fig
vicin
coupl
constant
j
hz
suggest
econfigur
along
doubl
bond
compound
nmr
spectra
exhibit
two
set
signal
attribut
zand
eisom
configur
along
doubl
bond
evalu
longrang
j
coupl
constant
determin
jhmbc
nmr
experi
small
valu
hz
agreement
zconfigur
along
doubl
bond
wherea
j
hz
correspond
eisom
tabl
conform
studi
compound
show
trivial
noesi
crosspeak
consequ
particular
conform
prefer
could
establish
compound
newli
synthes
deriv
lascorb
iminolascorb
acid
evalu
vitro
cytostat
effect
malign
human
tumour
cell
line
includ
cervic
carcinoma
hela
colorect
adenocarcinoma
murin
leukemia
acut
lymphoblast
leukemia
pancreat
carcinoma
hepatocellular
carcinoma
well
cytotox
effect
embryon
murin
fibroblast
tabl
supplementari
data
compound
test
pancreat
adenocarcinoma
cell
among
test
compound
exhibit
promin
antitumour
activ
compound
show
low
cytotox
effect
fibroblast
tabl
sever
deazapurin
deriv
laa
iminolaa
express
antiprolif
activ
cell
line
micromolar
concentr
rang
ic
mm
deriv
laa
ic
mm
deriv
ic
mm
respect
compound
cytotox
cell
deriv
laa
well
deriv
laa
iminolaa
show
pronounc
activ
cell
line
ic
mm
respect
amongst
deriv
laa
exhibit
cytotox
effect
fibroblast
regioisom
deriv
laa
deriv
laa
shown
moder
effect
ic
mm
respect
cell
line
ic
mm
respect
without
scheme
synthesi
novel
halogen
deriv
lascorb
iminolascorb
acid
deriv
laa
iminolaa
deriv
exhibit
promin
antitumour
activ
serv
model
molecul
develop
select
activ
antitumour
substrat
class
compound
newli
synthes
deriv
lascorb
iminolascorb
acid
tabl
ec
compound
order
found
refer
antihcmv
drug
ganciclovir
without
cytotox
effect
normal
human
embryon
lung
hel
cell
remov
benzyl
protect
group
hydroxyl
group
laa
moieti
compound
result
iminolaa
analogu
deriv
lost
antihcmv
activ
compar
activ
compound
deriv
laa
exhibit
lower
ec
valu
hcmv
strain
ec
mm
strain
ec
davi
strain
also
cytotox
effect
hel
cell
deriv
substitut
two
laa
moieti
exert
weak
activ
strain
vzv
tk
tk
ec
mm
respect
cytotox
effect
hel
cell
cc
mm
tabl
deriv
laa
substitut
posit
deazapurin
moieti
posit
exhibit
potenc
punta
toro
viru
ec
mm
strong
cytotox
effect
vero
cell
mcc
mm
mcc
mm
besid
compound
show
moder
activ
coxsacki
viru
vero
cell
ec
valu
mm
test
hela
cell
exhibit
activ
viru
ec
mm
tabl
deriv
disubstitut
two
laa
moieti
posit
exhibit
stronger
activ
punta
toro
viru
ec
mm
compar
compound
effect
concentr
need
reduc
punta
toro
viru
replic
compound
lower
compar
respect
dexstransulph
ribavirin
howev
compound
prove
cytotox
vero
cell
mcc
mm
tabl
amongst
deriv
laa
iminolaa
deriv
lascorb
acid
show
import
activ
human
cytomegaloviru
davi
cell
strain
inhibitori
concentr
similar
refer
antihcmv
drug
ganciclovir
also
compound
show
cytostat
effect
normal
human
embryon
lung
hel
cell
embryon
murin
fibroblast
immort
cell
ie
cervic
carcinoma
hela
madin
darbi
canin
kidney
mdck
crandellre
felin
kidney
cell
crfk
howev
remov
benzyl
protect
group
posit
laa
moieti
compound
scheme
synthesi
novel
alkyl
deriv
lascorb
iminolascorb
acid
reagent
condit
deadpph
hr
h
ii
nh
cr
h
tabl
h
nmr
chemic
shift
dppm
heh
coupl
constant
jhz
compound
numer
atom
molecular
skeleton
cf
fig
convers
laa
iminolaa
analogu
result
loss
antihcmv
activ
compound
regioisom
exhibit
compar
effect
punta
toro
viru
concomitantli
show
cytostat
effect
monkey
cell
line
vero
addit
compound
exert
moder
activ
coxsacki
viru
vero
cell
cytostat
effect
cervic
carcinoma
cell
hela
use
antivir
assay
deriv
laa
iminolaa
show
mark
cytostat
antivir
activ
contrast
deriv
lascorb
acid
iminolascorb
acid
exhibit
mark
effect
murin
leukemia
cell
line
micromolar
concentr
ic
lascorb
acid
deriv
also
display
effect
cell
addit
deriv
disubstitut
two
lascorb
acid
moieti
strong
activ
hela
cell
convers
lascorb
acid
moieti
compound
iminolascorb
acid
result
gain
compound
show
activ
pancreat
carcinoma
cell
line
deriv
shown
cytotox
effect
embryon
murin
fibroblast
furthermor
deriv
disubstitut
two
laa
moieti
posit
exhibit
even
stronger
activ
punta
toro
viru
compound
lower
ec
dexstransulph
ribavirin
respect
howev
compound
also
cytotox
uninfect
vero
cell
commerci
avail
chemic
purchas
sigma
aldrich
germani
acro
belgium
use
without
purif
solvent
use
synthesi
analyt
grade
puriti
dri
acetonitril
ch
cn
reflux
calcium
hydrid
cah
distil
store
molecular
siev
c
h
cl
dichloromethan
ch
cl
distil
phosphoru
pentoxid
p
store
molecular
siev
dri
sodium
also
store
molecular
siev
methanol
ch
oh
store
molecular
siev
without
distil
thf
predri
calcium
hydrid
reflux
sodium
benzophenon
ketyl
sodium
wire
benzophenon
distil
store
sodium
melt
point
determin
kofler
micro
hotstag
instrument
reichter
wien
uncorrect
precoat
merck
silica
gel
f
plate
use
thinlay
chromatographi
spot
visual
shortwav
uv
light
nm
column
chromatographi
perform
fluka
silica
gel
mm
petroleum
ether
ethylacet
dichloromethan
methanol
dichloromethan
mobil
phase
addit
purif
rechromatographi
afford
analyt
sampl
nmr
spectroscopi
h
gener
method
prepar
deriv
acid
suspens
anhydr
base
b
c
eq
nh
eq
hmd
ml
reflux
overnight
inert
atmospher
argon
excess
hmd
evapor
reduc
pressur
mmhg
silyl
base
obtain
solid
acid
dadbaa
eq
silyl
base
dissolv
dri
ml
stir
room
temperatur
argon
atmospher
tmsotf
eq
ad
reaction
tabl
inhibitori
effect
select
deriv
lascorb
iminolascorb
acid
growth
malign
cell
line
hela
well
cytotox
effect
embryon
murin
fibroblast
ammonia
induc
stir
solut
compound
mmol
anhydr
methanol
ml
ml
icecold
bath
c
satur
ammonia
mixtur
addit
stir
overnight
room
temperatur
methanol
surplu
ammonia
remov
reduc
pressur
purif
crude
residu
silica
gel
column
chromatographi
use
dichloro
methan
methanol
gave
desir
compound
respect
solid
procedur
prepar
deriv
acid
ethyliden
one
solut
triphenylphosphin
pph
mg
mmol
diethyl
azodicarboxyl
dead
ml
mmol
absolut
dri
tetrahydrofuran
thf
ml
stir
inert
argon
atmospher
one
hour
c
solut
e
mg
mmol
thf
ml
ad
reaction
mixtur
stir
anoth
h
c
temperatur
inert
atmospher
argon
acid
hdbaa
mg
mmol
dissolv
absolut
dri
thf
ml
ad
mixtur
stir
c
risen
gradual
room
temperatur
stir
overnight
crude
reaction
product
obtain
evapor
raw
reaction
mixtur
vaccuo
purifi
silica
gel
column
chromatographi
dichloromethan
methanol
rechromatoraphi
dichloromethan
methanol
result
gain
white
powder
compound
z
e
method
c
gener
procedur
prepar
deriv
iminolascorb
acid
ammonia
induc
stir
solut
compound
mmol
anhydr
methanol
ml
dioxan
ml
icecold
bath
c
satur
ammonia
mixtur
stir
overnight
room
temperatur
methanol
surplu
ammonia
remov
vacuum
purif
crude
residu
silica
gel
column
chromatographi
use
dichloromethan
methanol
gave
compound
transpar
oil
white
powder
respect
accord
procedur
c
ammonolysi
compound
mg
mmol
gave
solid
residu
purifi
silica
gel
column
chromatographi
dichloromethan
methanol
method
gener
procedur
prepar
deriv
acid
solut
triphenylphosphin
pph
eq
diethyl
azodicarboxyl
dead
eq
absolut
dri
tetrahydrofuran
thf
ml
stir
inert
argon
atmospher
one
hour
c
solut
base
f
g
eq
thf
ml
ad
reaction
mixtur
stir
hour
c
inert
atmospher
argon
acid
hdbaa
eq
solut
absolut
dri
thf
ml
ad
mixtur
stir
c
gradual
risen
room
temperatur
stir
overnight
crude
reaction
product
retain
evapor
raw
reaction
mixtur
vacuo
purifi
silica
gel
column
chromatographi
nhexan
ethylacet
dichloromethan
methanol
rechromatographi
nhexan
ethylacet
dichloromethan
methanol
gave
compound
ethyliden
one
accord
procedur
solut
f
mg
mmol
pph
mg
mmol
dead
ml
mmol
hdbaa
mg
mmol
thf
ml
stir
inert
argon
atmospher
c
h
room
temperatur
overnight
crude
reaction
product
purifi
silica
gel
column
chromatographi
nhexan
ethylacet
rechromatoraphi
nhexan
ethylacet
hcmv
assay
confluent
human
embryon
lung
hel
fibroblast
grown
microtit
plate
infect
human
cytomegaloviru
hcmv
strain
davi
pfu
per
well
incub
period
residu
viru
remov
infect
cell
incub
medium
contain
differ
concentr
test
compound
duplic
incub
day
c
virusinduc
cytopathogen
monitor
microscop
ethanol
fixat
stain
giemsa
antivir
activ
express
ec
compound
concentr
requir
reduc
virusinduc
cytopathogen
ec
calcul
graphic
plot
percentag
cytopathogen
function
concentr
compound
laboratori
wildtyp
vzv
strain
oka
thymidin
kinasedefici
vzv
strain
use
vzv
infect
confluent
hel
cell
grown
microtit
plate
inocul
vzv
input
pfu
per
well
incub
period
residu
viru
remov
vari
concentr
test
compound
ad
duplic
antivir
activ
express
ec
compound
concentr
requir
reduc
viral
plaqu
format
day
compar
untreat
control
cytostat
activ
measur
base
inhibit
cell
growth
hel
cell
seed
rate
cell
well
microtit
plate
allow
prolifer
h
medium
contain
differ
concentr
test
compound
ad
day
incub
c
cell
number
determin
coulter
counter
cytostat
concentr
calcul
cc
compound
concentr
requir
reduc
cell
prolifer
rel
number
cell
untreat
control
cc
valu
estim
graphic
plot
number
cell
percentag
control
function
concentr
test
compound
altern
cytotox
test
compound
express
minimum
cytotox
concentr
mcc
compound
concentr
caus
microscop
detect
alter
cell
morpholog
cell
line
hela
cervic
carcinoma
colorect
adenocarcinoma
metastat
pancreat
carcinoma
hepatocellular
carcinoma
pancreat
adenocarcinoma
cell
mous
embryon
fibroblast
cell
line
cultur
monolay
maintain
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
mm
lglutamin
uml
penicillin
mgml
streptomycin
humidifi
atmospher
co
c
panel
cell
line
inocul
onto
seri
standard
microtit
plate
day
cell
per
well
test
agent
ad
five
dilut
mm
incub
h
work
dilut
freshli
prepar
day
test
growth
medium
solvent
dmso
also
test
eventu
inhibitori
activ
adjust
concentr
work
concentr
dmso
concentr
never
exceed
h
incub
cell
growth
rate
evalu
perform
mtt
assay
experiment
determin
absorb
valu
transform
cell
percentag
growth
pg
use
formula
propos
nih
describ
previous
method
directli
reli
control
cell
number
day
assay
compar
growth
treat
cell
growth
untreat
cell
control
well
plate
e
result
therefor
percentil
differ
calcul
expect
valu
ic
valu
compound
calcul
doseerespons
curv
use
linear
regress
analysi
fit
mean
test
concentr
give
pg
valu
refer
valu
howev
test
concentr
produc
pg
exceed
respect
refer
level
effect
eg
pg
valu
given
cell
line
highest
test
concentr
assign
default
valu
screen
data
report
default
valu
preced
sign
test
point
perform
quadrupl
three
individu
experi
result
statist
analys
anova
tukey
posthoc
test
p
final
effect
test
substanc
evalu
plot
mean
percentag
growth
cell
type
comparison
control
dose
respons
graph
paper
describ
synthesi
new
type
deriv
lascorb
iminolascorb
acid
vitro
effect
growth
tumour
cell
line
normal
fibroblast
well
antivir
activ
compound
pronounc
antitumour
activ
deriv
laa
deriv
iminolaa
serv
lead
molecul
synthet
structur
modif
aim
develop
select
activ
antitumour
substrat
class
compound
addit
compound
also
model
skeleton
develop
even
effect
antihcmv
substrat
